Cargando…

Corticosteroid Resistance in Smokers—A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial

The CORTICO-COP trial showed that eosinophil-guided corticosteroid-sparing treatment for acute exacerbation of chronic obstructive pulmonary disease was non-inferior to standard of care and decreased the accumulated dose of systemic corticosteroids that patients were exposed to by approximately 60%....

Descripción completa

Detalles Bibliográficos
Autores principales:	Sivapalan, Pradeesh, Bikov, Andras, Suppli Ulrik, Charlotte, Lapperre, Therese Sophie, Mathioudakis, Alexander G., Højberg Lassen, Mats Christian, Grundtvig Skaarup, Kristoffer, Biering-Sørensen, Tor, Vestbo, Jørgen, Jensen, Jens-Ulrik S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234000/ https://www.ncbi.nlm.nih.gov/pubmed/34205765 http://dx.doi.org/10.3390/jcm10122734

Ejemplares similares

Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

The Impact of Social Distancing in 2020 on Admission Rates for Exacerbations in Asthma: A Nationwide Cohort Study
por: Toennesen, Louise Lindhardt, et al.
Publicado: (2022)

Alcohol Consumption and the Risk of Acute Respiratory Distress Syndrome in COVID-19
por: Lassen, Mats Christian Højbjerg, et al.
Publicado: (2021)

A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol
por: Sivapalan, Pradeesh, et al.
Publicado: (2017)

Major cardiovascular events in patients with severe COPD with and without asthma: a nationwide cohort study
por: Bonnesen, Barbara, et al.
Publicado: (2022)

Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study
por: Kamstrup, Peter, et al.
Publicado: (2021)

Influenza and cardiovascular disease pathophysiology: strings attached
por: Skaarup, Kristoffer Grundtvig, et al.
Publicado: (2023)

Fibrin degradation products and survival in patients with chronic obstructive pulmonary disease: a protocolized prospective observational study
por: Kamstrup, Peter, et al.
Publicado: (2023)

TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease
por: Saeed, Mohamad Isam, et al.
Publicado: (2020)

The clinical application of longitudinal layer specific strain as a diagnostic and prognostic instrument in ischemic heart diseases: A systematic review and meta-analysis
por: Sharma, Shreeya, et al.
Publicado: (2023)

Does inhaled corticosteroid use affect the risk of  COVID-19-related death?
por: Jordan, Alexander, et al.
Publicado: (2021)

Strain Imaging and Ventricular Arrhythmia
por: Bjerregaard, Caroline Løkke, et al.
Publicado: (2023)

Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study
por: Vilstrup, Frida, et al.
Publicado: (2023)

Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits
por: Mathioudakis, Alexander G, et al.
Publicado: (2020)

Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method
por: Jordan, Alexander, et al.
Publicado: (2023)

Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial Population
por: Kamstrup, Peter, et al.
Publicado: (2022)

Lung ultrasound findings following COVID-19 hospitalization: A prospective longitudinal cohort study
por: Espersen, Caroline, et al.
Publicado: (2022)

Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients: a nationwide cohort study
por: Altaraihi, Sarah, et al.
Publicado: (2023)

Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial
por: Kamstrup, Peter, et al.
Publicado: (2023)

SARS-CoV-2 and risk of psychiatric hospital admission and use of psychopharmaceuticals: A nationwide registry study of 4,585,083 adult Danish citizens
por: Rømer, Valdemar, et al.
Publicado: (2023)

Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care
por: Tupper, Oliver Djurhuus, et al.
Publicado: (2018)

Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate—A Nationwide Study of 58,580 Outpatients
por: Bergsøe, Christina Marisa, et al.
Publicado: (2021)

Opportunistic screening for COPD in primary care: a pooled analysis of 6,710 symptomatic smokers and ex-smokers
por: Katsimigas, Andreas, et al.
Publicado: (2019)

Novel Perspectives Regarding the Pathology, Inflammation, and Biomarkers of Acute Respiratory Distress Syndrome
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Focused lung ultrasound to predict respiratory failure in patients with symptoms of COVID-19: a multicentre prospective cohort study
por: Skaarup, Søren Helbo, et al.
Publicado: (2022)

Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study
por: Skaarup, Kristoffer Grundtvig, et al.
Publicado: (2021)

Treatment Response Biomarkers in Asthma and COPD
por: Meteran, Howraman, et al.
Publicado: (2021)

Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis
por: Savran, Osman, et al.
Publicado: (2023)

Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study
por: Heerfordt, Christian Kjer, et al.
Publicado: (2023)

The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients
por: Jordan, Alexander, et al.
Publicado: (2021)

Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study
por: Mathioudakis, Alexander G., et al.
Publicado: (2021)

Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better
por: Gregersen, Thorbjørn Lomholt, et al.
Publicado: (2013)

Myocardial Work in Patients Hospitalized With COVID‐19: Relation to Biomarkers, COVID‐19 Severity, and All‐Cause Mortality
por: Olsen, Flemming Javier, et al.
Publicado: (2022)

Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring Streptococcus pneumoniae Infection. A Multiregional Epidemiological Study
por: Heerfordt, Christian Kjer, et al.
Publicado: (2023)

Inhaled corticosteroids and risk of lower respiratory tract infection with Moraxella catarrhalis in patients with chronic obstructive pulmonary disease
por: Johnsen, Rikke Helin, et al.
Publicado: (2023)

Oral ketone esters acutely improve myocardial contractility in post-hospitalized COVID-19 patients: A randomized placebo-controlled double-blind crossover study
por: Wodschow, Helena Zander, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g9sua77glste9nr715cnt9itf8